Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
1 Until recently, a typical weight loss clinical trial for GLP-1 receptor agonists would follow a few hundred patients for a year
Prescriptions are often approved after a provider reviews your intake form, sometimes without a live telehealth visit, unless your state requires it
These may be an option while retatrutide completes the approval process
Retatrutide dosing should only be determined by a qualified healthcare provider based on your individual health status, goals, and tolerance
Tirzepatide (Zepbound), a dual GLP-1/GIP receptor agonist, is also approved for weight management, though evidence in post-bariatric populations is still emerging
Angle the needle so that the tip is touching the inside glass wall of the vial
US$ 20.51
US$ 26.96
US$ 20.64
US$ 23.86
